AL amiloidozė (Lithuanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "AL amiloidozė" in Lithuanian language version.

refsWebsite

Global rank Lithuanian rank

low place

4,595^th place

low place

3,677^th place

4^th place

12^th place

ascopubs.org

Kastritis et al. Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol 28:1031-1037, 2010. http://jco.ascopubs.org/content/28/6/1031
Palladini et al. New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes. J Clin Oncol 30:4541-4549, 2012. http://jco.ascopubs.org/content/30/36/4541

Bochtler et al. Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared to monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability. Blood 111:4700-4705, 2008. http://bloodjournal.hematologylibrary.org/content/111/9/4700
Cibeira et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood 118:4346-4352, 2011. http://bloodjournal.hematologylibrary.org/content/118/16/4346
Palladini et al. Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. Blood 103:2936-2938, 2004. http://bloodjournal.hematologylibrary.org/content/103/8/2936

Kyle et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 79:1817-1822, 1992. http://www.ncbi.nlm.nih.gov/pubmed?term=1558973